Compare Organon Pharma Indonesia Tbk. (SCPI) vs Triwira Insanlestari Tbk. (TRIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Triwira Insanlestari Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Triwira Insanlestari Tbk. trades at Rp50 (market cap 60B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| SCPI | TRIL | |
|---|---|---|
Market Cap | 104.4B | 60B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Triwira Insanlestari Tbk.
PT Triwira Insanlestari Tbk (the company) was established on 26 Oct 1992 based on Notaries Deed No. 185 of Erny Tjandrasasmita, S.H.The Companys articles of association has been amended several times, most recently by notarial deed No. 6 of Lenny Janis Ishak, S.H., dated Sep 17, 2007, concerning among others, the change company's name, par value and public offering.
Read more on TRIL →
